Tectonic Therapeutic to Participate in Upcoming Investor Conferences
Tectonic Therapeutic (NASDAQ: TECX) announced that CEO Alise Reicin will participate in fireside chats at two upcoming healthcare investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tectonic Therapeutic (NASDAQ: TECX) announced that CEO Alise Reicin will participate in fireside chats at two upcoming healthcare investor conferences. The Stifel 2026 Healthcare Conference chat is scheduled for November 11, 2026, at 4:00 PM ET; the Piper Sandler 38th Annual Healthcare Conference chat is set for December 2, 2026, at 10:00 AM ET. Both events take place in New York, where management will also host one-on-one investor meetings.
Details
Market Reaction – TECX
On Nov 9, the day this news came out, the latest delayed price for TECX is 6.20% above the previous close. Our momentum scanner has recorded 11 alerts for this stock so far that day. The latest delayed price is $21.92.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WATERTOWN, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will participate in fireside chats at the upcoming Stifel 2026 Healthcare Conference, and the Piper Sandler 38th Annual Healthcare Conference.
Stifel 2026 Healthcare Conference
| Date: | November 11, 2026 |
| Time: | 4:00 PM ET |
| Location: | New York, NY |
| Format: | Fireside Chat |
| Presenter: | Alise Reicin, MD, President and Chief Executive Officer |
| Webcast: | Link |
Piper Sandler 38th Annual Healthcare Conference
| Date: | December 2, 2026 |
| Time: | 10:00 AM ET |
| Location: | New York, NY |
| Format: | Fireside Chat |
| Presenter: | Alise Reicin, MD, President and Chief Executive Officer |
| Webcast: | Link |
The live fireside chats can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website at www.tectonictx.com. Once the live events have concluded, a replay of both events will be available on the Company’s website for approximately 90 days.
The Tectonic management team will host one-on-one meetings during both conferences. Interested investors should contact their Stifel and Piper representatives to schedule meetings.
About Tectonic
Tectonic Therapeutic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit https://tectonictx.com/ and follow us on LinkedIn.
Contacts: Investors: Dan Ferry LifeSci Advisors (617) 430-7576 daniel@lifesciadvisors.com Media: Kathryn Morris The Yates Network (914) 204-6412 kathryn@theyatesnetwork.com